ClinicalTrials.Veeva

Menu

Uterine Microbiome in Women with Repeated Implantation Failure and Normal Fertile Women

G

Ghent University Hospital (UZ)

Status

Completed

Conditions

Repeated Implantation Failure
Normal Fertile

Treatments

Other: Vaginal swab + endometrial biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT03405883
BE670201733152

Details and patient eligibility

About

Characterization of the uterine microbiome in women with repeated implantation failure as well as in normal fertile women.

Full description

In the midluteal phase of the cycle, a vaginal swab and endometrial biopsy will be obtained.

Enrollment

13 patients

Sex

Female

Ages

18 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women between their 18th and 40th birthdays (max 39 years and 364 days at the day of signing the informed consent)
  • Able to understand, read and speak Dutch and hence to provide written and oral informed consent
  • Negative serological tests for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), Rapid plasma reagin (RPR) for syphilis

Exclusion criteria

  • Hormonal contraception in current cycle
  • Presence of intra-uterine device
  • Antibiotic treatment in the current cycle

Trial design

13 participants in 2 patient groups

RIF (women with repeated implantation failure)
Description:
Transfer of at least 5 good quality embryos in IVF or ICSI cycles, without achieving pregnancy
Treatment:
Other: Vaginal swab + endometrial biopsy
NF (normal fertile women)
Description:
Spontaneous conception or conception after max 9 IUI cycles
Treatment:
Other: Vaginal swab + endometrial biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems